A retrospective study of mucocutaneous lesions of SLE patients and their systemic implications
Keywords:Unilateral episcleritis, Retinal vasculitis, Lupus nephritis, CNS lupus
Background: SLE is a systemic disease with multiorgan involvement occuring very rarely, if so, it has a very grave prognosis if not detected early. Our study enlightens about the evolution of mucocutaneous lesions which can serve as an eye opener for early detection of systemic involvement.
Methods: A descriptive study was conducted in the Department of Dermatology at a tertiary care centre from May 2017 to April 2018 retrospectively. From 15 confirmed cases of SLE a critical retrospective analysis of symptom complex evolution was done and thus a clinical correlation of evolution of mucocutaneous lesions and systemic involvement was attempted.
Results: Out of the fifteen patients in our study comprising various age groups (4-51 years), mean age group was 29.76 years. 14 (93%) were female patients and 1 (6.6%) male patient. Oral ulcerations, Non-scarring alopecia and vasculitic lesions were predominant (3 patients-80%) followed by photosensitivity and cheilitis (9 patients- 60%). Systemic involvement was present in 9 (60%), out of which one (6%) patient had lupus nephritis and 3 patients (20%) had CNS lupus, 2 (13%) had chronic unilateral scleritis, 2 (13%) had interstitial lung disease, one (6%) had coronary heart disease. Mucocutaneous lesions preceded the systemic involvement in 88.8% of cases, with mean duration being 3 years (4 months – 10 years).
Conclusions: Mucocutaneous lesions could serve as an eye opener for diagnosis of SLE, which is always a diagnosis made out of high degree of suspicion apart from certain mucocutaneous lesions serving as an ominous sign of system involvement in SLE.
Lee LA. Cutaneous lupus in infancy and childhood. Lupus. 2010;19:1112–7.
Md Noh UK, Zahidin AZA, Yong TK. Retinal vasculitis in systemic lupus erythematosus: an indication of active disease. Clin Pract. 2012;2(2):54.
Rowell NR. Some historical aspects of skin disease in lupus erythematosus. Lupus. 1997;6:76–83.
Abbas AK, Lichtman AH, Pober JS. Self tolerance and autoimmunity. 2nd edn. In: Cellular and Molecular Immunology. 1994: 384.
McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005;11:85-9.
Bastian BC Annexins in cancer and autoimmune diseases. Cell Mol Life Sci. 1997;53:554-6.
Mamoune A, Saraux A, Delaunay JL, Le Goff P, Youinou P, et al. Autoantibodies to CD45 in systemic lupus erythematosus. J Autoimmun. 1998;11:485-8.
Boehm J, Orth T, Van Nguyen P, Söling HD Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS-A antigen. Eur J Clin Invest. 1994;24:248-57.
Arbuckle MR. Development of Autoantibodies before the clinical onset of Systemic Lupus Erythematosus. N Engl J Med. 2003;349:1526-33.
Kabin DI, Malkinson FD. Lupus erythematosus and calcinosis cutis. Arch Dermatol. 1969;100:17–22.
Pramatarov K. Discoid lupus erythematosus of the soles. J Dermatol. 1989;16:511.
Rowell NR. The natural history of lupus erythematosus. Clin Exp Dermatol. 1984;9:217–31.
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–7.
Her MY, Song JY, Kim DY. Hypocomplementemic Urticarial Vasculitis in Systemic Lupus Erythematosus. J Korean Med Sci. 2009;24(1):184-6.
Yung S, Chan TM. Mechanisms of Kidney Injury in Lupus Nephritis –the Role of Anti-dsDNA Antibodies. Frontiers Immunol. 2015;6:475.
Lun Hon K, Leung AKC. Neonatal Lupus Erythematosus. Autoimmune Dis. 2012;2012:301274.
Dougal MA, Evans LS, McClellan KR, Robinson J Central retinal artery occlusion in systemic lupus erythematosus. Ann Ophthalmol. 1983;15:38-40.
Goldstein I, Wexler D Retinal vascular disease in a case of acute lupus erythematosus disseminatus. Arch Ophthalmol. 1932;8:852-7.
Goldman FD, Gilman AL, Hollenback C. Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties. Blood. 2000;95(11):3460–6.
Prabu VN, Agrawal S. Systemic lupus erythematosus and tuberculosis: A review of complex interactions of complicated diseases. J Postgraduate Med. 2010;56(3):244–7.